172 Results for "

Ppi

" in MedChemExpress (MCE) Product Catalog:
Products (172)

172 Results for "Ppi" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-105049
CAS No.: 189345-04-8
Purity:  96.14%
Synonyms: T-91825; Ppi-0903M
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

Ceftaroline (T-91825) is a cephalosporin compound and the active form of Ceftaroline fosamil (HY-14737). Ceftaroline exhibits activity against Gram-positive bacteria, Gram-negative bacteria, and some anaerobic bacteria. Ceftaroline binds to penicillin-binding proteins 2 and 2A, thereby inhibiting the synthesis of bacterial peptidoglycan and cell wall, and acts as a bactericide, synergist, and resistance inhibitor. Ceftaroline can be used in research related to complicated skin and soft tissue infections, community-acquired pneumonia, Enterococcus faecalis infective endocarditis, and bacterial infections .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13534
CAS No.: 183552-38-7
Purity:  99.90%
Synonyms: R3827; Ppi 149
Target:  

GnRH Receptor

Research Areas:  

Endocrinology Cancer

Abarelix (R3827; PPI 149) is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer treatment.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139301
CAS No.: 2355377-13-6
Purity:  99.20%
Target:  

HSP

Research Areas:  

Cancer

DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-131592
CAS No.: 520-31-0
Purity:  97.73%
Tricetin is a potent competitive inhibitor of the Keap1-Nrf2 Protein Protein Interaction (PPI). Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100341
CAS No.: 312271-03-7
Purity:  ≥98.0%
Research Areas:  

Others

M2I-1 is a Mad2 inhibitor targeting the binding of Mad2 to Cdc20, an essential protein-protein interaction (PPI) within the spindle assembly checkpoint (SAC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19319
CAS No.: 1628316-74-4
MI-136 is an inhibitor of the menin-MLL protein-protein interaction (PPI), with an IC50 of 31 nM and a Kd of 23.6 nM. MI-136 shows to block AR signaling and has the potential for the study in castration-resistant tumors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117233
CAS No.: 1500080-17-0
Purity:  99.63%
Target:  

β-catenin Wnt

Research Areas:  

Metabolic Disease Cancer

UU-T02 is a novel potent, selective small-molecule inhibitor of β-Catenin/T-cell factor protein-protein interaction (β-catenin/Tcf PPI) with a Ki of 1.36 μM . UU-T02 inhibits canonical Wnt signaling and the growth of colorectal cancer cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13534A
CAS No.: 547741-72-0
Purity:  99.89%
Synonyms: Ppi 149 Acetate; R 3827 Acetate
Target:  

GnRH Receptor

Research Areas:  

Endocrinology Cancer

Abarelix Acetate (PPI 149 Acetate; R 3827 Acetate) is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0819
CAS No.: 89412-79-3
Raddeanin A is an oleanane-type triterpenoid saponin with oral activity. Raddeanin A inhibits SRC, mTOR, JNK, VEGFR2, NLRP3 inflammasome, Wnt/β-catenin, Wee1, PI3K/AKT signaling pathway, MAPK/ERK signaling pathway, AR-FL, AR-Vs, and downregulates the expression of p-PI3K and p-AKT. Raddeanin A inhibits osteoclast formation, bone resorption, osteolysis, cancer cell invasion, migration, proliferation, angiogenesis and epithelial-mesenchymal transition, while induces apoptosis, cell cycle arrest, ROS production, immunogenic cell death and dendritic cell maturation. Raddeanin A improves blood-retinal barrier function, alleviates inflammation, regulates the tumor microenvironment, and enhances the activity of anti-PD-1 antibody. Raddeanin A is applicable to the research of breast cancer-associated osteolysis, human osteosarcoma, colorectal cancer, glioblastoma, Alzheimer's disease, cholangiocarcinoma, melanoma, non-small cell lung cancer, castration-resistant prostate cancer and multiple myeloma .
loading...
    loading...
Cat. No.: HY-163573
CAS No.: 3033990-61-0
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

FANCM-BTR PPI-IN-1 (Compound 32) is a FANCM/BTR interaction inhibitor that blocks the localization of FANCM to telomeres. FANCM-BTR PPI-IN-1 exhibits anticancer activity against osteosarcoma .
loading...
    loading...
Cat. No.: HY-202699
Target:  

Ras p38 MAPK PERK MEK

Research Areas:  

Cancer

SHOC2-RAS PPI-IN-1 is a SHOC2-NRAS interaction inhibitor with IC50 of 0.048 μM and a Kd of 0.065 μM for SHOC2. SHOC2-RAS PPI-IN-1 inhibits RAS/MAPK signalling and downregulates MEK and ERK phosphorylation. SHOC2-RAS PPI-IN-1 can inhibit cells proliferation in RAS-mutant cancer models. SHOC2-RAS PPI-IN-1 can be used for the research of RAS-mutant cancers .
loading...
    loading...
Cat. No.: HY-P2992
CAS No.: 9024-82-2
Synonyms: PPase
Target:  

Fungal

Research Areas:  

Infection

Inorganic pyrophosphatase is a ubiquitous enzyme that converts pyrophosphate (PPi) to phosphate and, in this way, controls numerous biosynthetic reactions that produce PPi as a byproduct. Inorganic pyrophosphatase, Saccharomyces cerevisiae is an Inorganic pyrophosphatase isolated from Saccharomyces cerevisiae .
loading...
    loading...
Cat. No.: HY-101447A
CAS No.: 1992052-49-9
Purity:  99.79%
Synonyms: EPH 116 hydrochloride
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

SI-2 (EPH 116 hydrochloride) is a highly promising SRC-3 inhibitor (PPI). SI-2 (EPH 116 hydrochloride) has a much improved toxicity and pharmacokinetic profile, with acceptable oral availability .
loading...
    loading...
Cat. No.: HY-132300
CAS No.: 2632259-93-7
Purity:  97.09%
Target:  

β-catenin

Research Areas:  

Cancer

ZW4864 is an orally active and selective β catenin/B-Cell lymphoma 9 protein protein interaction (β catenin/BCL9 PPI) inhibitor. ZW4864 inhibits β catenin/BCL9 PPI with a Ki value of 0.76 μM and an IC50 value of 0.87 μM .
loading...
    loading...
Cat. No.: HY-153193
CAS No.: 2765539-59-9
Research Areas:  

Metabolic Disease

LSN3160440 is an allosteric modulator of GLP-1R, which acts as a protein–protein interaction (PPI) stabilizer or molecular glue to assist in the adhesion of inactive GLP-1 (9-36) NH2 on GLP-1R .
loading...
    loading...
Cat. No.: HY-124191
CAS No.: 1303533-81-4
Purity:  99.94%
Synonyms: Ppi-668 hydrochloride
Target:  

HCV

Research Areas:  

Infection

Ravidasvir hydrochloride (PPI-668 hydrochloride) is a pan-genotypic inhibitor for hepatitis C virus (HCV) NS5A protein. Ravidasvir hydrochloride inhibits the replication of HCV, with EC50 of 0.12, 0.01 and 1.14 nM, for HCV gt-1a, gt-1b, and gt-3a replicons, respectively. Ravidasvir hydrochloride exhibits good pharmacokinetic characters in rats .
loading...
    loading...
Cat. No.: HY-13731
CAS No.: 431077-35-9
Purity:  99.67%
Target:  

MetAP

Research Areas:  

Inflammation/Immunology Cancer

PPI-2458 is a potent, orally active, selective and irreversible inhibitor of methionine aminopeptidase-2 (MetAP-2). PPI-2458 can be used for arthritis and lymphoma research .
loading...
    loading...
Cat. No.: HY-151576
CAS No.: 3031536-71-4
Purity:  98.70%
Research Areas:  

Cancer

PRMT5:MEP50 PPI is a novel PRMT5:MEP50 protein-protein interaction (PRMT5:MEP50 PPI) inhibitor, shows anti-tumor activity and anti-proliferative activity of lung and prostate cancer cells .
loading...
    loading...
Cat. No.: HY-145587
CAS No.: 2353522-15-1
Purity:  99.96%
Synonyms: PBI-200; Ppi-5278
Target:  

Tyrosinase Trk Receptor

Research Areas:  

Inflammation/Immunology Cancer

Paltimatrectinib (compound I-147) is a potent tyrosine kinase inhibitor with an IC50 of <10 nM for tropomyosin kinases A (TrkA). Paltimatrectinib has the potential for cancer and inflammatory diseases .
loading...
    loading...
Cat. No.: HY-149010
CAS No.: 2254492-08-3
Purity:  98.18%
Target:  

Keap1-Nrf2

Research Areas:  

Neurological Disease

NXPZ-2 is an orally active Keap1-Nrf2 protein–protein interaction (PPI) inhibitor with a Ki value of 95 nM, EC50 value of 120 and 170 nM. NXPZ-2 can dose-dependently ameliorate Aβ[1-42]-Induced cognitive dysfunction, improve brain tissue pathological changes in Alzheimer’s disease (AD) mouse by increasing neuron quantity and function. NXPZ-2 can inhibit oxidative stress by increasing Nrf2 expression levels and promoting its cytoplasm to nuclear translocation, which is helpful for Keap1-Nrf2 PPI inhibitors and AD associated disease research .
loading...
    loading...